Atlas FDA

UROLOGIX PROSTATRON SYSTEM

FDA premarket approval P950014/S026 · decided 2008-07-16

Approval details

PMA number
P950014
Supplement
S026
Supplement type
Normal 180 Day Track
Supplement reason
Change Design/Components/Specifications/Material
Trade name
UROLOGIX PROSTATRON SYSTEM
Generic name
System, hyperthermia, rf/microwave (benign prostatic hyperplasia),thermotherapy
Applicant
Urologix, Inc.
Date received
2008-03-14
Decision date
2008-07-16
Days to decision
124 days
Decision code
APPR
Product code
MEQ
Advisory committee
Gastroenterology, Urology
Expedited review
No
Location
Plymouth, MN
Statement
APPROVAL FOR DESIGN MODIFICATIONS WHICH INCLUDE A NEW CATHETER TIP MATERIAL, RED MARK ADHESIVE, BONDING ADHESIVES, INJECTION MOLD FOR MANUFACTURING THE CATHETER TIP, AND A NEW STERILE BALLOON INFLATION STOPCOCK. THE PRODUCTION OF THE PROSTAPROBE TYPE II, SILICONE, BLUE TREATMENT CATHETER (PART NUMBER 410053-004) WILL BE MANUFACTURED AT MEDTECH COSTA RICA, SA, COSTA RICA, CENTRAL AMERICA.

Class III intelligence, same tools

PMAs share the API, exports and alerts with 510(k) data - watch an applicant and hear about every approval.

510(k) clearances by this applicant

RecordFirmDate
Prostiva RF Therapy Generator, Prostiva RF Therapy Hand Piece, Prostiva RF Therapy Return Electrode, Prostiva RF Therapy Tubing System, Prostiva RF Therapy Telescope (K142248)Urologix, Inc.2015-02-20